Entia Biosciences, Inc. (ERGO)
OTCMKTS · Delayed Price · Currency is USD
0.0006
0.00 (0.00%)
At close: Apr 28, 2026
Entia Biosciences Market Cap
Entia Biosciences has a market cap or net worth of $20.44 thousand as of May 6, 2026. Its market cap has decreased by -95.71% in one year.
Market Cap
20.44K
Enterprise Value
n/a
Revenue
265.47K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since January 18, 2008, Entia Biosciences's market cap has decreased from 3.26M to 20.44K, a decrease of -99.37%. That is a compound annual growth rate of -24.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 20.44K | 100.01% |
| Dec 31, 2025 | 10.22K | 50.00% |
| Dec 13, 2024 | 6.81K | - |
| Dec 27, 2022 | 6.81K | -86.67% |
| Dec 31, 2021 | 51.09K | -88.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nascent Biotech | 34.57K |
| America Great Health | 21.15K |
| Carisma Therapeutics | 20.92K |
| Health Sciences Group | 20.51K |
| Scopus BioPharma | 16.83K |
| NanoLogix | 16.29K |
| Regenicin | 15.35K |
| Vaxxinity | 12.68K |